Biocon Ltd. (BIOCON) Share Price Rises 3.12% Amid Strong Trading Volume
- August 6, 2026
- Posted by: Harsh Piplani
- Category: News
Biocon Ltd. Share Price rises 3.12% to Rs 438.25, marking a significant gain in the Large Cap category.
Biocon Ltd. Share Price today witnessed a notable increase of 3.12%, closing at Rs 438.25. This rise comes as part of a strong trading session, with Biocon Ltd. achieving a market capitalisation of Rs 69,286.45 crore. The stock opened at Rs 427.2 and reached a high of Rs 438.6, demonstrating robust investor interest. As a Large Cap stock, Biocon Ltd. 12% rise.
The healthcare sector, where Biocon Ltd. operates, has been under the spotlight, and today’s price action reflects the company’s strong position within this industry. The trading volume was significant, with a total of 3,947,976 shares exchanged, indicating heightened market activity. This surge in volume further underscores the stock’s attractiveness to investors at this juncture.
Biocon Ltd. (BIOCON) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 438.25 |
| Previous Close | Rs 425 |
| Today's Change | +Rs 13.25 (+3.12%) |
| Day Open | Rs 427.2 |
| Day High | Rs 438.6 |
| Day Low | Rs 421.5 |
| Current Volume (BSE) | 2,65,199 |
| BSE Traded Volume | 2,65,199 |
| NSE Traded Volume | 36,82,777 |
| Combined NSE + BSE Volume | 39,47,976 |
| Turnover | Rs 11.62 crore |
| Market Capitalisation | Rs 69,286.45 crore |
| Market Cap Category | Large Cap |
Biocon Ltd. (BIOCON) traded at Rs 438.25. versus the previous close of Rs 425, a rise of 3.12%. The stock opened at Rs 427.2, reached Rs 438.6, touched Rs 421.5. Reported volume was 2,65,199.
Biocon Ltd. (BIOCON) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 69,286.45 crore |
The healthcare sector benchmark, comprising 198 companies, offers a median P/E of 26.29 and an average P/E of 91.99. Biocon Ltd.’s performance can be contextualized within this sector framework, although direct comparisons are limited by
Despite this, the company’s large market cap and active trading volume suggest a strong market presence. The sector’s median ROE of 10.77% and ROCE of 13.35% provide a benchmark for evaluating Biocon Ltd.’s profitability and efficiency, although specific figures for the company are not available.
Investors should consider these sector benchmarks when assessing Biocon Ltd.’s fundamental strength, keeping in mind the company’s significant market cap and active trading dynamics.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Benchmark Scope | same sector |
| Benchmark Median P/E | 26.29x |
| Benchmark Average P/E | 91.99x |
| Benchmark P/E Range | 3.23x to 3,428.55x |
| Benchmark Median P/B | 1.92x |
| Benchmark Median ROE | 10.77% |
| Benchmark Median ROCE | 13.35% |
| Company Market Capitalisation | Rs 69,286.45 crore |
| Benchmark Median Market Cap | Rs 139.72 crore |
Biocon Ltd. (BIOCON) is classified under sector: Healthcare.
Track today’s top gainers through the Univest top gainers screener. The peer table below provides the company-level comparison.
Biocon Ltd. is a prominent player in the healthcare sector, which includes 198 companies. The sector’s P/E ratio ranges from a minimum of 3.23 to a maximum of 3428.55, with a median of 26.29. This wide range highlights the diversity within the sector, where Biocon Ltd. operates.
The sector’s P/B ratio median is 1.92, with an average of 2.56, indicating varying levels of market valuation across companies. The median ROE of 10.77% and ROCE of 13.35% serve as benchmarks for assessing company performance within the sector.
Biocon Ltd.’s market capitalisation of Rs 69,286.45 crore positions it well above the sector’s median of Rs 139.72 crore, underscoring its significant presence in the industry. The company’s performance today reflects its robust standing within the healthcare sector, which continues to attract investor interest.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Dishman Carbogen Amcis Ltd. | DCAL | 2,943.6 | 31.4 | 0.46 | -2.89 | -0.26 |
| Hikal Ltd. | HIKAL | 2,812.49 | 0 | 2.39 | 15.22 | 16.15 |
| Kwality Pharmaceuticals Ltd. | KPL | 2,684.11 | 39.39 | 8.02 | 28.21 | 26.35 |
| Beta Drugs Ltd. | BETA | 2,621.81 | 63.25 | 10.01 | 18.65 | 22.17 |
| Panacea Biotec Ltd. | PANACEABIO | 2,566.71 | 0 | 3.08 | 0 | 5.36 |
Biocon Ltd. (BIOCON) has a market capitalisation of Rs 69,286.45 crore. Among the 5 peers shown, 0 have a larger market capitalisation.
Biocon Ltd. competes with several notable peers in the healthcare sector. Dishman Carbogen Amcis Ltd., with a market cap of Rs 2943.6 crore, and Hikal Ltd., with Rs 2812.49 crore, are among the key competitors. Kwality Pharmaceuticals Ltd. and Beta Drugs Ltd. also present significant market capitalisations of Rs 2684.11 crore and Rs 2621.81 crore, respectively.
While specific P/E, ROE, and ROCE figures for Biocon Ltd. are not provided, the peer companies exhibit diverse metrics. For instance, Kwality Pharmaceuticals Ltd. boasts a P/E of 39.39, ROE of 28.21%, and ROCE of 26.35%, reflecting strong profitability. These comparisons highlight the competitive landscape in which Biocon Ltd. operates.
Why Investors Are Watching Biocon Ltd.
Biocon Ltd. has captured investor attention with its 3.12% share price rise today. The company’s strong market cap and active trading volume underscore its significance in the healthcare sector.
- Price Action: 3.12% rise to Rs 438.25.
- Technical Position: Strong trading volume indicates investor interest.
- Fundamental Context: Large market cap within the healthcare sector.
- Sector Positioning: Operates in a diverse and competitive sector.
Investors should monitor Biocon Ltd.’s performance in the context of sector trends and peer dynamics, considering its robust market presence and active trading activity.
About Biocon Ltd.
Biocon Ltd. is a leading player in the healthcare sector, focusing on biopharmaceuticals and research services. The company operates across various segments, including pharmaceuticals, biosimilars, and research services, catering to a global clientele.
With a strong emphasis on innovation and research, Biocon Ltd. has established itself as a key player in the industry. The company’s diverse product portfolio and strategic partnerships contribute to its competitive edge in the market.
Biocon Ltd.’s commitment to quality and sustainability further enhances its reputation in the healthcare sector, making it a preferred choice for investors seeking exposure to this dynamic industry.
Track Biocon Ltd. Share Price on Univest
Use Biocon Ltd. (BIOCON) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top gainers lists and related market analysis.
Investors can track Biocon Ltd. Share Price, along with technical indicators, fundamental ratios, and shareholding patterns, on Univest. The platform offers insights into 52-week levels and market trends, providing a comprehensive view of the stock’s performance.
Stay informed about Biocon Ltd.’s market movements and sector dynamics by leveraging Univest’s detailed analytics and real-time data.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
What was Biocon Ltd.'s share price today?
Ans. Biocon Ltd.'s share price today rose by 3.12% to close at Rs 438.25. The stock opened at Rs 427.2 and reached a high of Rs 438.6 during the trading session.
How much did Biocon Ltd.'s share price increase today?
Ans. Biocon Ltd.'s share price increased by 3.12% today, marking a significant gain in the Large Cap category. The stock closed at Rs 438.25. The stock moved 3.12% during the session.
How does Biocon Ltd.'s market cap compare to the sector median?
Ans. Biocon Ltd.'s market cap of Rs 69,286.45 crore is significantly higher than the sector median of Rs 139.72 crore, highlighting its strong market presence. The company operates in the Healthcare sector.
What are the sector benchmarks for P/E and ROE?
Ans. The sector benchmarks for P/E and ROE are a median of 26.29 and 10.77%, respectively, providing a context for evaluating company performance. The relevant peer median P/E is 26.29x. The peer average P/E is 91.99x.
Who are Biocon Ltd.'s key competitors?
Ans. Key competitors of Biocon Ltd. include Dishman Carbogen Amcis Ltd., Hikal Ltd., and Kwality Pharmaceuticals Ltd., among others in the healthcare sector. Comparable listed companies include Dishman Carbogen Amcis Ltd., Hikal Ltd., Kwality Pharmaceuticals Ltd.
Where can I track Biocon Ltd.'s share price?
Ans. You can track Biocon Ltd.'s share price, technical indicators, and market insights on Univest, offering comprehensive analytics and real-time data. The stock moved 3.12% during the session. The intraday range extended from Rs 421.5 to Rs 438.6.
